Xela Domains Logo

RXRATES.COM

WELCOME TO RXRATES.COM

RXRATES.COM is fee-schedule English: Rx Rates—MAC fee-schedule portals, pharmacy rate cards, and contracted-rate education—not RxPriceCheck.com cash widgets or RxReprice.com claim engines.

Best-fit buyers: PBM contracting desks; pharmacy association rate tools; MAC education publishers; defensive holders. Exact-fit launch: an Rx Rates portal with schedule tiles, MAC FAQ, and download CTA.

ASHP reports U.S. prescription drug spending of $915.2 billion in 2025—the contracted-rate climate MAC schedules sit inside.[1] KFF's FY2024 Medicaid outpatient data show rebates of about $58.4 billion—illustrating how rate and rebate mechanics dominate U.S. Rx economics.[2] That spend × rebate spine frames why exact RxRates inventory matters—not an invented fee-schedule TAM.

Why Choose RXRATES.COM

BUY NOW - $45,188

Buy Now — RXRATES.COM. Own the rxrates hostname.

MAKE AN OFFER

Purchase RXRATES.COM today through our trusted partners:

WHAT DOES ABIGAIL IRONS THINK?

Abigail Irons

"RxRates.com is fee-schedule inventory—MAC rate hubs, not pricecheck or reprice twins."

Abigail Irons, Customer Service Representative
Contact Abigail Irons via Email

FAQs

Who buys RxRates.com?

PBM contracting desks, pharmacy association rate tools, MAC education publishers, defensive holders.

What figures are cited?

ASHP: Rx $915.2B (2025); KFF: Medicaid rebates ~$58.4B FY2024.

Vs RxPriceCheck.com?

MAC fee schedules vs consumer cash lookup—unique.

Rate data included?

No—domain only.

Contact Us

Feel free to reach out to explore the potentials of RXRATES.COM for your business. 📬

📧 Email: info@xeladomains.com
📞 Phone: (858) 429-9352

Social Networks

Follow us on Instagram and LinkedIn to stay updated with the latest on RXRATES.COM and more.

Instagram | LinkedIn

REFERENCES

  1. ASHP / PR Newswire — U.S. prescription drug spending $915.2B in 2025 (+12.7%); trajectory >$1T in 2026
  2. KFF — FY2024 Medicaid outpatient Rx: ~$104B gross spending; rebates ~$58.4B (~56% of gross); net ~$46B